About NewAmsterdam Pharma Co. NV 
NewAmsterdam Pharma Co. NV
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 25 Schemes (20.92%)
Foreign Institutions
Held by 70 Foreign Institutions (23.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2025)
Net Profit:
-72 Million
Pharmaceuticals & Biotechnology
USD 3,848 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.97
-23.63%
5.29






